KNTE
Price:
$2.65
Market Cap:
$124.99M
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-D...[Read more]
Industry
Biotechnology
IPO Date
2020-12-03
Stock Exchange
NASDAQ
Ticker
KNTE
According to Kinnate Biopharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 71.17M. This represents a change of -28.88% compared to the average of 100.07M of the last 4 quarters.
The mean historical Enterprise Value of Kinnate Biopharma Inc. over the last ten years is 936.59M. The current 71.17M Enterprise Value has changed 659.86% with respect to the historical average. Over the past ten years (40 quarters), KNTE's Enterprise Value was at its highest in in the December 2019 quarter at 1.62B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.
Average
936.59M
Median
1.01B
Minimum
56.56M
Maximum
1.68B
Discovering the peaks and valleys of Kinnate Biopharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 1.68B
Minimum Annual Increase = -76.79%
Minimum Annual Enterprise Value = 56.56M
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 56.56M | -76.79% |
| 2022 | 243.72M | -62.88% |
| 2021 | 656.52M | -51.87% |
| 2020 | 1.36B | -15.52% |
| 2019 | 1.61B | -4.12% |
The current Enterprise Value of Kinnate Biopharma Inc. (KNTE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
318.93M
5-year avg
787.10M
10-year avg
936.59M
Kinnate Biopharma Inc.’s Enterprise Value is greater than NGM Biopharmaceuticals, Inc. (69.72M), less than Graybug Vision, Inc. (112.82M), less than Decibel Therapeutics, Inc. (102.82M), less than Paratek Pharmaceuticals, Inc. (351.99M), less than Tourmaline Bio, Inc. (1.20B), greater than aTyr Pharma, Inc. (45.86M), greater than RVL Pharmaceuticals plc (16.09M), less than Pardes Biosciences, Inc. (75.90M), less than Sesen Bio, Inc. (125.94M), less than Aadi Bioscience, Inc. (183.79M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 69.72M | $128.53M | |
| 112.82M | $120.98M | |
| 102.82M | $123.37M | |
| 351.99M | $127.83M | |
| 1.20B | $1.23B | |
| 45.86M | $44.17M | |
| 16.09M | $3.14M | |
| 75.90M | $135.19M | |
| 125.94M | $127.96M | |
| 183.79M | $94.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kinnate Biopharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kinnate Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kinnate Biopharma Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kinnate Biopharma Inc. (KNTE)?
What is the 3-year average Enterprise Value for Kinnate Biopharma Inc. (KNTE)?
What is the 5-year average Enterprise Value for Kinnate Biopharma Inc. (KNTE)?
How does the current Enterprise Value for Kinnate Biopharma Inc. (KNTE) compare to its historical average?